AKT1 and neoplasm: Low‐dose HBBR could interfere with the expression of cyclin‐D1 and E1 to induce G1 cycle arrest and induce caspase pathway to increase apoptosis, and may inhibit the PI3 K/Akt pathway in A549 cells, thus significantly inhibiting tumor growth.278